1. Home
  2. EVH vs NBTX Comparison

EVH vs NBTX Comparison

Compare EVH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • NBTX
  • Stock Information
  • Founded
  • EVH 2011
  • NBTX 2003
  • Country
  • EVH United States
  • NBTX France
  • Employees
  • EVH N/A
  • NBTX N/A
  • Industry
  • EVH Other Consumer Services
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVH Consumer Discretionary
  • NBTX Health Care
  • Exchange
  • EVH Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • EVH 1.0B
  • NBTX 868.8M
  • IPO Year
  • EVH 2015
  • NBTX 2020
  • Fundamental
  • Price
  • EVH $8.09
  • NBTX $20.81
  • Analyst Decision
  • EVH Strong Buy
  • NBTX Strong Buy
  • Analyst Count
  • EVH 15
  • NBTX 1
  • Target Price
  • EVH $17.07
  • NBTX $8.00
  • AVG Volume (30 Days)
  • EVH 3.1M
  • NBTX 112.7K
  • Earning Date
  • EVH 11-06-2025
  • NBTX 09-30-2025
  • Dividend Yield
  • EVH N/A
  • NBTX N/A
  • EPS Growth
  • EVH N/A
  • NBTX N/A
  • EPS
  • EVH N/A
  • NBTX N/A
  • Revenue
  • EVH $2,195,920,000.00
  • NBTX $11,930,711.00
  • Revenue This Year
  • EVH N/A
  • NBTX N/A
  • Revenue Next Year
  • EVH $28.38
  • NBTX $74.67
  • P/E Ratio
  • EVH N/A
  • NBTX N/A
  • Revenue Growth
  • EVH N/A
  • NBTX N/A
  • 52 Week Low
  • EVH $7.06
  • NBTX $2.76
  • 52 Week High
  • EVH $27.42
  • NBTX $22.51
  • Technical
  • Relative Strength Index (RSI)
  • EVH 42.03
  • NBTX 70.34
  • Support Level
  • EVH $7.84
  • NBTX $19.11
  • Resistance Level
  • EVH $9.63
  • NBTX $22.64
  • Average True Range (ATR)
  • EVH 0.45
  • NBTX 1.64
  • MACD
  • EVH -0.04
  • NBTX 0.61
  • Stochastic Oscillator
  • EVH 21.73
  • NBTX 80.68

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: